Diphencyprone for the treatment of alopecia areata: More data and new aspects

Archives of Dermatology

Volumn 138, Issue 1, 2002, Pages 112-113

  Happle, Rudolf ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHENCYPRONE; STEROID;

ALOPECIA AREATA; DISEASE ASSOCIATION; EDITORIAL; HAIR GROWTH; HAIR LOSS; HUMAN; PATIENT SATISFACTION; PRIORITY JOURNAL; PROGNOSIS; RELAPSE; TREATMENT OUTCOME;

ALOPECIA AREATA; CLINICAL TRIALS; CYCLOPROPANES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FOLLOW-UP STUDIES; HUMANS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 0036142551     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (8)

1. Predictive model for immunotherapy of alopecia areata with diphencyprone
2. Prognostic factors in the treatment of alopecia areata with diphenylcyclopropenone
3. Topical immunotherapy in alopecia areata: Anamnestic and clinical criteria of prognostic significance
4. Treatment of alopecia areata with diphenylcyclopropenone
5. Topical immunotherapy for alopecia areata: Re-evaluation of 139 cases after an additional follow-up period of 19 months
6. Alopecia areata update
7. Topical immunotherapy in alopecia areata: What, how and why?
8. Current and potential agents for the treatment of alopecia areata